World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
95
Citations
28497
World Ranking
913
National Ranking
30

Medicine

D-Index
95
Citations
28498
World Ranking
10175
National Ranking
401

Bart O. Roep publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bart O. Roep sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 407 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bart O. Roep D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bart O. Roep sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 95 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Internal medicine

His main research concerns Immunology, Type 1 diabetes, Autoimmunity, Islet and Antigen. His study focuses on the intersection of Immunology and fields such as Transplantation with connections in the field of Mannan-binding lectin. Diabetes mellitus covers Bart O. Roep research in Type 1 diabetes.

His work deals with themes such as Internal medicine, Insulin and Pathogenesis, which intersect with Diabetes mellitus. His work carried out in the field of Autoimmunity brings together such families of science as Cytotoxic T cell, Beta cell and Immunotherapy. His Antigen study combines topics in areas such as T cell, Autoantibody and Proinsulin.

His most cited work include:

  • Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes (683 citations)
  • Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients (454 citations)
  • Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients (432 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Type 1 diabetes, Autoimmunity, Islet and Immune system. In most of his Immunology studies, his work intersects topics such as Transplantation. His Type 1 diabetes research integrates issues from Internal medicine, Insulin and Disease.

His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology. Bart O. Roep has researched Autoimmunity in several fields, including Autoantibody, Beta cell, Pancreas and Immunotherapy. The Epitope study which covers Human leukocyte antigen that intersects with Allele and Genotype.

He most often published in these fields:

  • Immunology (74.15%)
  • Type 1 diabetes (58.05%)
  • Autoimmunity (35.61%)

What were the highlights of his more recent work (between 2018-2021)?

  • Type 1 diabetes (58.05%)
  • Diabetes mellitus (27.32%)
  • Immune system (32.68%)

In recent papers he was focusing on the following fields of study:

Bart O. Roep mainly investigates Type 1 diabetes, Diabetes mellitus, Immune system, Islet and Immunology. His Type 1 diabetes research includes themes of Bioinformatics, Intensive treatment, C-peptide and Autoimmunity, Disease. In his study, Disease progression is strongly linked to T cell, which falls under the umbrella field of Autoimmunity.

His research in Immune system intersects with topics in Antigen and Cell biology. His Islet research is multidisciplinary, incorporating elements of Transplantation and Genotype. Bart O. Roep connects Immunology with Context in his research.

Between 2018 and 2021, his most popular works were:

  • Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells. (89 citations)
  • Diabetes relief in mice by glucose-sensing insulin-secreting human α-cells. (89 citations)
  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes (51 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Internal medicine

Bart O. Roep mostly deals with Type 1 diabetes, Diabetes mellitus, Immune system, Disease and Autoimmunity. Type 1 diabetes is often connected to Bioinformatics in his work. Bart O. Roep focuses mostly in the field of Diabetes mellitus, narrowing it down to topics relating to Internal medicine and, in certain cases, Cell Plasticity and Cellular differentiation.

His studies deal with areas such as Carbohydrate metabolism, Antigen and Cell biology as well as Immune system. His work in Disease addresses issues such as Precision medicine, which are connected to fields such as Endotype, Genetic predisposition, Translational research and Islet. As a member of one scientific family, Bart O. Roep mostly works in the field of Immunotherapy, focusing on Peptide and, on occasion, Autoimmune disease.

Best Publications

  • Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

    Shelley Lindley;Colin M. Dayan;Amanda Bishop;Bart O. Roep

  • Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

    Ken T. Coppieters;Francesco Dotta;Natalie Amirian;Peter D. Campbell

  • Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

    Francesco Dotta;Stefano Censini;Astrid G. S. van Halteren;Lorella Marselli

  • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

    Sefina Arif;Timothy I. Tree;Thomas P. Astill;Jennifer M. Tremble

  • Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

    Bart O Roep;Bart O Roep;Sofia Thomaidou;René van Tienhoven;Arnaud Zaldumbide

  • The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure

    Bart O. Roep

  • Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1

    Wendy W. J. Unger;Sandra Laban;Fleur S. Kleijwegt;Arno R. van der Slik

  • CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope

    Ania Skowera;Richard J. Ellis;Ruben Varela-Calviño;Sefina Arif

  • Expert consensus document: A consensus on the medical treatment of acromegaly

    Andrea Giustina;Philippe Chanson;David Kleinberg;Marcello D. Bronstein

  • Development of type 1 diabetes despite severe hereditary B-cell deficiency.

    Stephan Martin;Dorothea Wolf-Eichbaum;Gaby Duinkerken;Werner A. Scherbaum

  • Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes

    Gabrielle G. M. Pinkse;Odette H. M. Tysma;Cees A. M. Bergen;Michel G. D. Kester

  • Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

    Manuela Battaglia;Simi Ahmed;Mark S. Anderson;Mark A. Atkinson

  • Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

    T. P. Di Lorenzo;M. Peakman;B. O. Roep

  • KIR in Type 1 Diabetes: Disparate Distribution of Activating and Inhibitory Natural Killer Cell Receptors in Patients Versus HLA-Matched Control Subjects

    Arno R. van der Slik;Bobby P.C. Koeleman;Willem Verduijn;G. Jan Bruining

  • Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes

    Bart O Roep;Mark Atkinson;Matthias von Herrath

  • The vitamin D receptor gene FokI polymorphism: functional impact on the immune system.

    Evelyne van Etten;Lieve Verlinden;Annapaula Giulietti;Elizabeth Ramos-Lopez

  • Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial

    Pieter de Groot;Tanja Nikolic;Silvia Pellegrini;Valeria Sordi

  • Antigen Targets of Type 1 Diabetes Autoimmunity

    Bart O Roep;Mark Peakman

  • Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3).

    Astrid G.S. van Halteren;Evelyne van Etten;Esther C. de Jong;Roger Bouillon

  • Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.

    Alexandra Zhernakova;Behrooz Z. Alizadeh;Behrooz Z. Alizadeh;Marianna Bevova;Miek A. van Leeuwen

  • Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review.

    Jeroen M K de Filette;Joeri J Pen;Lore Decoster;Thomas Vissers

  • Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

    B. O. Roep;I. Stobbe;G. Duinkerken;J. J. Van Rood

Frequent Co-Authors

Mark Peakman
Mark Peakman King's College London
Bobby P.C. Koeleman
Bobby P.C. Koeleman Utrecht University
Jan W. Drijfhout
Jan W. Drijfhout Leiden University Medical Center
Daniel Pipeleers
Daniel Pipeleers Vrije Universiteit Brussel
Behrooz Z. Alizadeh
Behrooz Z. Alizadeh University Medical Center Groningen
Timothy I. M. Tree
Timothy I. M. Tree King's College London
Peter A. van Veelen
Peter A. van Veelen Leiden University Medical Center
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Hubert Kolb
Hubert Kolb Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your skill set through related online degrees can open diverse healthcare career opportunities. Many professionals look towards accelerated nursing programs to build a strong clinical foundation. Programs like accelerated nurse practitioner programs offer a fast-track path for aspiring nurse practitioners aiming to specialize in immunology-related patient care.

Non-nurses seeking entry into the healthcare sector may find online accelerated nursing programs for non nurses particularly valuable. These options help candidates quickly gain essential nursing credentials, which can complement immunology expertise.

For prospective students concerned about admission challenges, exploring the easiest accelerated nursing programs to get into and best easiest lpn programs to get into can provide accessible entry points. These programs offer flexible options with less competitive requirements, ideal for applicants balancing rigorous academic preparation alongside practical healthcare experience.

By understanding these pathways, students and professionals can better map out their journey within health sciences, combining immunology with nursing expertise for a robust and impactful career.

Best Scientists Citing Bart O. Roep

Trending Scientists

Recently Published Articles